IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Alcoholic liver disease (ALD) is characterized by steatosis and upregulation of proinflammatory cytokines, including IL-1β. IL-1β, type I IL-1 receptor (IL-1R1), and IL-1 receptor antagonist (IL-1Ra) are all important regulators of the IL-1 signaling complex, which plays a role in inflammation. Furthermore, IL-1β maturation is dependent on caspase-1 (Casp-1). Using IL-1Ra-treated mice as well as 3 mouse models deficient in regulators of IL-1β activation (Casp-1 and ASC) or signaling (IL-1R1), we found that IL-1β signaling is required for the development of alcohol-induced liver steatosis, inflammation, and injury. Increased IL-1β was due to upregulation of Casp-1 activity and inflammasome activation. The pathogenic role of IL-1 signaling in ALD was attributable to the activation of the inflammasome in BM-derived Kupffer cells. Importantly, in vivo intervention with a recombinant IL-1Ra blocked IL-1 signaling and markedly attenuated alcohol-induced liver inflammation, steatosis, and damage. Furthermore, physiological doses of IL-1β induced steatosis, increased the inflammatory and prosteatotic chemokine MCP-1 in hepatocytes, and augmented TLR4-dependent upregulation of inflammatory signaling in macrophages. In conclusion, we demonstrated that Casp-1-dependent upregulation of IL-1β and signaling mediated by IL-1R1 are crucial in ALD pathogenesis. Our findings suggest a potential role of IL-1R1 inhibition in the treatment of ALD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other macrophage-secreted cytokines that may promote HSC activation include PDGF, tumor necrosis factor alpha (TNFα), and interleukin 1 beta ( IL-1β) (65-69).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [66]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Toll-like receptors and their crosstalk with other innate receptors in infection and immunity
Kawai, T., & Akira, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.006 · Cited by 3,658 · cited 1×
“Given the partial overlap of signaling pathways downstream of TLR4 and IL-1R1 (22), we hypothesized that IL-1β augments TLR4-dependent signaling in immune cells.”
BackgroundImmunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466 · cited 6×
“Although Casp-1 cleaves IL-1β, IL-18, and IL-33 (8), and IL-1R1 recognizes IL-1α, IL-1β, and IL-1Ra (16), our study provides several lines of evidence that IL-1β — not IL-18, IL-33, or IL-1α — is the primary cytokine that mediates the pathogenic effects of activated inflammasome in ALD.”
BackgroundInfluentialFitzgerald, M., Hayward, I. P., Thomas, A. C., Campbell, J. H., & CAMPBELL, G. R. (1995) · Cited by 2,552
O'Shea, R. S., Dasarathy, S., & McCullough, A. J. (2010) · Hepatology · doi:10.1002/hep.23258 · Cited by 1,077
Opal, S. M., Fisher, C. J., Dhainaut, J.-F. A., Vincent, J.-L., Brase, R., Lowry, S. F., Sadoff, J. C., Slotman, G. J., Levy, H., Balk, R. A., et al. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00010 · Cited by 865 · cited 2×
“In contrast to anti-TNF approaches, whose utility was compromised by infectious complications (1, 5), administration of IL-1Ra has demonstrated an excellent safety profile, and its use has not been associated with adverse reactions or superinfections with long-term treatment in patients with rheumatoid arthritis (38)…”
BackgroundToll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
Miura, K., Kodama, Y., Inokuchi, S., Schnabl, B., Aoyama, T., Ohnishi, H., Olefsky, J. M., Brenner, D. A., & Seki, E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.052 · Cited by 741 · cited 3×
“MCP-1 is a chemokine required for the pathogenesis of ALD (24) that, when present in high doses, induces lipid accumulation in hepatocytes (12).”
BackgroundSerum levels of cytokines in chronic liver diseases
Tilg, H., Wilmer, A., Vogel, W., Herold, M., Nölchen, B., Judmaier, G., & Huber, C. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91122-k · Cited by 739 · cited 1×
“IL-1β is a potent proinflammatory cytokine (6), whose levels are increased in patients with ALD (7).”
BackgroundAcetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome
Imaeda, A. B., Watanabe, A., Sohail, M. A., Mahmood, S., Mohamadnejad, M., Sutterwala, F. S., Flavell, R. A., & Mehal, W. Z. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35958 · Cited by 607 · cited 1×
“Emerging data have provided evidence for the role of IL-1 signaling in acute and chronic liver injury of diverse origin, including acetaminophen-induced liver damage (11), nonalcoholic steatohepatitis (12), liver fibrosis (13), and immune-mediated liver injury (14).”
BackgroundIL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G
Lefrançais, E., Roga, S., Gautier, V., Gonzalez-de-Peredo, A., Monsarrat, B., Girard, J.-P., & Cayrol, C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115884109 · Cited by 594 · cited 16×
“First, alcohol administration in mice significantly increased IL-1β and IL-33, whereas levels of IL-1α and IL-18 remained unchanged.”
BackgroundInfluentialInactivation of Kupffer cells prevents early alcohol-induced liver injury
Adachi, Y., Bradford, B. U., Gao, W., Bojes, H. K., & Thurman, R. G. (1994) · Hepatology · doi:10.1002/hep.1840200227 · Cited by 556 · cited 3×
“org Volume 122 Number 10 October 2012 3487 and in the pathogenesis of ALD (2, 3, 20).”
BackgroundBode, C., Kugler, V., & Bode, J. C. (1987) · Journal of Hepatology · doi:10.1016/s0168-8278(87)80003-x · Cited by 529 · cited 1×
“Essential for the pathogenesis of ALD (20), TLR4 signaling is activated by gut-derived LPS that increases in the serum after alcohol feeding (21), activates nuclear transcription factors including NF-κB, and upregulates production of inflammatory mediators (reviewed in ref.”
BackgroundIimuro, Y., Gallucci, R. M., Luster, M. I., Kono, H., & Thurman, R. G. (1997) · Hepatology · doi:10.1002/hep.510260621 · Cited by 497 · cited 1×
“Our data and reports of others demonstrate that the mechanisms by which IL-1β exerts its pathogenic effects involve sensitization of hepatocytes to cytotoxicity induced by TNF-α (14, 29), upregulation of lipid synthesis in hepatocytes (12), activation of hepatic stellate cells (30), maintenance of macrophages in infla…”
BackgroundToll–Like Receptor 4 Is Involved in the Mechanism of Early Alcohol–Induced Liver Injury in Mice
Uesugi, T., Froh, M., Arteel, G. E., Bradford, B. U., & Thurman, R. G. (2001) · Hepatology · doi:10.1053/jhep.2001.25350 · Cited by 488 · cited 2×
“org Volume 122 Number 10 October 2012 3487 and in the pathogenesis of ALD (2, 3, 20).”
BackgroundSalliot, C., Dougados, M., & Gossec, L. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.083188 · Cited by 477 · cited 1×
“In contrast to anti-TNF approaches, whose utility was compromised by infectious complications (1, 5), administration of IL-1Ra has demonstrated an excellent safety profile, and its use has not been associated with adverse reactions or superinfections with long-term treatment in patients with rheumatoid arthritis (38)…”
BackgroundNaveau, S., Chollet-Martin, S., Dharancy, S., Mathurin, P., Jouet, P., Piquet, M.-A., Davion, T., Oberti, F., Broët, P., & Emilie, D. (2004) · Hepatology · doi:10.1002/hep.20206 · Cited by 446 · cited 2×
“In contrast to anti-TNF approaches, whose utility was compromised by infectious complications (1, 5), administration of IL-1Ra has demonstrated an excellent safety profile, and its use has not been associated with adverse reactions or superinfections with long-term treatment in patients with rheumatoid arthritis (38)…”
BackgroundHritz, I., Mandrekar, P., Velayudham, A., Catalano, D., Dolganiuc, A., Kodys, K., Kurt‐Jones, E., & Szabo, G. (2008) · Hepatology · doi:10.1002/hep.22470 · Cited by 415 · cited 2×
“or Sirius red and analyzed by microscopy, as we previously described (40).”
MethodSelf-citationA Recent Perspective on Alcohol, Immunity, and Host Defense
Szabo, G., & Mandrekar, P. (2009) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00842.x · Cited by 387 · cited 1×
“Discussion ALD is tightly linked to liver inflammation and steatosis in humans as well as in experimental models (25).”
BackgroundII. Alcoholic liver injury involves activation of Kupffer cells by endotoxin
Thurman, R. G. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.275.4.g605 · Cited by 377 · cited 2×
“org Volume 122 Number 10 October 2012 3487 and in the pathogenesis of ALD (2, 3, 20).”
BackgroundBala, S., Marcos, M., Kodys, K., Csak, T., Catalano, D., Mandrekar, P., & Szabo, G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.145870 · Cited by 361 · cited 1×
“Szabo, unpublished observations) and in animal models of ALD (33).”
BackgroundSelf-citationThe precursor form of IL-1α is an intracrine proinflammatory activator of transcription
Werman, A., Werman-Venkert, R., White, R., Lee, J.-K., Werman, B., Krelin, Y., Voronov, E., Dinarello, C. A., & Apte, R. N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308705101 · Cited by 346 · cited 1×
“For example, nuclear translocation of IL-1α that serves as an intracrine activator of proinflammatory responses (27), or induction of Th2-immune responses by IL-33 (28), may contribute to ALD.”
BackgroundMandrekar, P., Ambade, A., Lim, A., Szabo, G., & Catalano, D. (2010) · Hepatology · doi:10.1002/hep.24599 · Cited by 285 · cited 2×
“MCP-1 is a chemokine required for the pathogenesis of ALD (24) that, when present in high doses, induces lipid accumulation in hepatocytes (12).”
BackgroundInterleukin-1 participates in the progression from liver injury to fibrosis
Gieling, R. G., Wallace, K., & Han, Y.-P. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90564.2008 · Cited by 281 · cited 1×
“Emerging data have provided evidence for the role of IL-1 signaling in acute and chronic liver injury of diverse origin, including acetaminophen-induced liver damage (11), nonalcoholic steatohepatitis (12), liver fibrosis (13), and immune-mediated liver injury (14).”
BackgroundInnate immunity in alcoholic liver disease
Gao, B., Seki, E., Brenner, D. A., Friedman, S., Cohen, J. I., Nagy, L., Szabo, G., & Zakhari, S. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00537.2010 · Cited by 230 · cited 1×
“Second, IL-1β exerted its effects through paracrine signaling, which is considered to be the primary mode of interaction between immune cells and parenchymal cells in the liver (4, 15, 26).”
BackgroundInterleukin-1β and the Autoinflammatory Diseases
Dinarello, C. A. (2009) · New England Journal of Medicine · doi:10.1056/nejme0811014 · Cited by 226 · cited 3×
“IL-1β is a potent proinflammatory cytokine (6), whose levels are increased in patients with ALD (7).”
BackgroundPastorino, J. G., & Hoek, J. B. (2000) · Hepatology · doi:10.1053/he.2000.7013 · Cited by 195
Li, H., Fan, X., Kovi, R. C., Jo, Y., Moquin, B., Konz, R., Stoicov, C., Kurt-Jones, E., Grossman, S. R., Lyle, S., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2665 · Cited by 194 · cited 1×
“This protocol achieves full depletion of KC in acceptor livers (Supplemental Figure 5) and greater than 90% reconstitution of BM-derived cells (19).”
MethodSelf-citationAnakinra for rheumatoid arthritis
Mertens, M., & Singh, J. A. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005121.pub3 · Cited by 179 · cited 1×
“Treatment with IL-1Ra significantly improves symptoms in patients with rheumatoid arthritis (9) or autoinflammatory syndromes (6); unlike anti-TNF therapy, it is not associated with infectious complications (10).”
BackgroundGranowitz, E., Clark, B., Vannier, E., Callahan, M., & Dinarello, C. (1992) · Blood · doi:10.1182/blood.v79.9.2356.2356 · Cited by 165 · cited 1×
“This finding is supported by previous studies showing that IL-1 signaling is required for the full expression of NF-κB–induced inflammatory cytokines in human leukocytes (17, 23) and consistent with our in vivo data that KC-specific deficiency of Casp-1 (Figure 9, J–L), global deficiency of ASC (Figure 4, C–I) or IL-1…”
ResultEffects of Alcohol and Oxidative Stress on Liver Pathology: The Role of the Mitochondrion
Cahill, A., Cunningham, C. C., Adachi, M., Ishii, H., Bailey, S. M., Fromenty, B., & Davies, A. (2002) · Alcoholism: Clinical & Experimental Research · doi:10.1097/00000374-200206000-00022 · Cited by 138
Petrasek, J., Dolganiuc, A., Csak, T., Nath, B., Hritz, I., Kodys, K., Catalano, D., Kurt-Jones, E., Mandrekar, P., & Szabo, G. (2011) · Hepatology · doi:10.1002/hep.24059 · Cited by 117 · cited 1×
“Second, IL-1β exerted its effects through paracrine signaling, which is considered to be the primary mode of interaction between immune cells and parenchymal cells in the liver (4, 15, 26).”
BackgroundSelf-citationPetrasek, J., Dolganiuc, A., Csak, T., Kurt–Jones, E. A., & Szabo, G. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.08.020 · Cited by 112 · cited 19×
“N) inhibited upregulation of IL-1β, TNF-α, IL-6, IL-10, and MCP-1 in ALD.”
BackgroundInfluentialSelf-citationGranowitz, E., Vannier, E., Poutsiaka, D., & Dinarello, C. (1992) · Blood · doi:10.1182/blood.v79.9.2364.2364 · Cited by 100 · cited 4×
“5 mg/kg demonstrates a halflife of 2–3 hours and therapeutic serum levels that are detectable 6–12 hours after injection (17).”
BackgroundResultInfluentialSANDBERG, J.-O., EIZIRIK, D. L., & SANDLER, S. (2003) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1997.3771275.x · Cited by 80 · cited 1×
“effects were excluded by heat inactivation of IL-1Ra (39).”
BackgroundCosgrove, B. D., Cheng, C., Pritchard, J. R., Stolz, D. B., Lauffenburger, D. A., & Griffith, L. G. (2008) · Hepatology · doi:10.1002/hep.22335 · Cited by 75
McClain, C., Barve, S., Joshi‐Barve, S., Song, Z., Deaciuc, I., Chen, T., & Hill, D. (2005) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000189276.34230.f5 · Cited by 57 · cited 2×
“Second, IL-1β exerted its effects through paracrine signaling, which is considered to be the primary mode of interaction between immune cells and parenchymal cells in the liver (4, 15, 26).”
BackgroundCawthorne, C., Prenant, C., Smigova, A., Julyan, P., Maroy, R., Herholz, K., Rothwell, N., & Boutin, H. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01068.x · Cited by 54 · cited 1×
“administration (Figure 6C), most likely due to the pronounced renal accumulation (Figure 6D) and rapid elimination of IL-1Ra in rodents (18).”
BackgroundSgroi, A., Gonelle-Gispert, C., Morel, P., Baertschiger, R. M., Niclauss, N., Mentha, G., Majno, P., Serre-Beinier, V., & Buhler, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025442 · Cited by 45 · cited 1×
“A protective effect of the blockade of IL-1 signaling has also been shown in TLR9-associated liver injury (14), recovery after partial hepatectomy in mice (36), and liver failure induced by d-galactosamine (37).”
BackgroundShinoda, M., Tilles, A. W., Kobayashi, N., Wakabayashi, G., Takayanagi, A., Totsugawa, T., Harada, H., Obara, H., Suganuma, K., Berthiaume, F., et al. (2006) · Journal of Surgical Research · doi:10.1016/j.jss.2006.08.009 · Cited by 33 · cited 1×
“A protective effect of the blockade of IL-1 signaling has also been shown in TLR9-associated liver injury (14), recovery after partial hepatectomy in mice (36), and liver failure induced by d-galactosamine (37).”
BackgroundZhang, Y., & Yao, X. (2011) · Apmis · doi:10.1111/j.1600-0463.2011.02816.x · Cited by 25 · cited 1×
“Our data and reports of others demonstrate that the mechanisms by which IL-1β exerts its pathogenic effects involve sensitization of hepatocytes to cytotoxicity induced by TNF-α (14, 29), upregulation of lipid synthesis in hepatocytes (12), activation of hepatic stellate cells (30), maintenance of macrophages in infla…”
BackgroundHou, F. F., Boyce, J. A., Zhang, Y., & Owen, W. F. (2000) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2000.00899.x · Cited by 11 · cited 1×
“Our data and reports of others demonstrate that the mechanisms by which IL-1β exerts its pathogenic effects involve sensitization of hepatocytes to cytotoxicity induced by TNF-α (14, 29), upregulation of lipid synthesis in hepatocytes (12), activation of hepatic stellate cells (30), maintenance of macrophages in infla…”
Background
Research works printed but not linked: 4
- Thurman, 1998, Am J Physiol., 275, G605
- Mertens, 2009, Cochrane Database Syst Rev., CD005121
- Imaeda, 2009, J Clin Invest., 119, 305
- 10.1111/j.1530-0277.2002.tb02621.x · doi:10.1111/j.1530-0277.2002.tb02621.x · Paper page
Cited by
Molecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024
Resolving the fibrotic niche of human liver cirrhosis at single-cell level
Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784
Liver Macrophages in Tissue Homeostasis and Disease
Krenkel, O., & Tacke, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.11 · Cited by 1,424
Seitz, H. K., Bataller, R., Cortez-Pinto, H., Gao, B., Gual, A., Lackner, C., Mathurin, P., Mueller, S., Szabo, G., & Tsukamoto, H. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0014-7 · Cited by 1,271
Mouse model of chronic and binge ethanol feeding (the NIAAA model)
Bertola, A., Mathews, S., Ki, S. H., Wang, H., & Gao, B. (2013) · Nature Protocols · doi:10.1038/nprot.2013.032 · Cited by 1,213
Metadata
- Authors
- Petrasek, J., Bala, S., Csak, T., Lippai, D., Kodys, K., Menashy, V., Barrieau, M., Min, S.-Y., Kurt-Jones, E. A., & Szabo, G.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- ORCID
- Min, So-Yun
- Venue
- Journal of Clinical Investigation
- Published
- 2012-10-01
- Volume
- 122
- Issue
- 10
- Pages
- 3476-3489
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3461900
- OpenAlex
- W1975752601
- Cited by
- 735
- References
- 41
- Citations by year
- 2026: 24 · 2025: 55 · 2024: 61 · 2023: 70 · 2022: 63 · 2021: 37 · 2020: 55 · 2019: 50 · 2018: 66 · 2017: 58 · 2016: 55 · 2015: 55 · 2014: 49 · 2013: 33 · 2012: 4
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@UMassChan (submittedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (R01AA017729, AA017729)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 32520, P30DK032520)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- interleukin-1 receptor antagonist, alcoholic steatohepatitis, alcoholic liver disease, IL-1β signaling, inflammasome, caspase-1, IL1R1, Kupffer cells, hepatic steatosis, liver inflammation, MCP-1, TLR4, macrophages, hepatocytes
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Ethanol, Animals, Carrier Proteins, Drug Evaluation, Preclinical, Fatty Liver, Alcoholic, Female, Kupffer Cells, Liver Cirrhosis, Mice, Inbred C57BL, Recombinant Proteins, Signal Transduction, Up-Regulation, Mice, Knockout, Chemokine CCL2, Caspase 1, Hepatocytes, Toll-Like Receptor 4, Mice, Receptors, Interleukin-1 Type I, Interleukin-1alpha, Interleukin-1beta, Interleukin 1 Receptor Antagonist Protein, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.